Related Articles
Meta-analysis of the role of bevacizumab in extensive stage small cell lung cancer
Topotecan or other agents as second‑line therapy for relapsed small‑cell lung cancer: A meta‑analysis of randomized studies
Retrospective analysis of capecitabine and oxaliplatin (XELOX) plus bevacizumab as a first‑line treatment for Japanese patients with metastatic colorectal cancer
Evaluation of the efficacy of PD‑1/PD‑L1 inhibitor plus bevacizumab and chemotherapy for the treatment of patients with driver gene‑negative advanced‑stage lung adenocarcinoma: A retrospective cohort study
Comparison between cisplatin plus vinorelbine and cisplatin plus docetaxel in the treatment of advanced non‑small‑cell lung cancer: A meta‑analysis of randomized controlled trials